Another finding in this study was a tendency for improved survival for both AML and MDS patients who displayed hypermethylation of the PLK2 CpG island, suggesting that the gene may have a utility as a prognostic biomarker in myeloid malignancies. Here, PLK2 is linked to acute myeloid leukemia.